Adverse Systemic Reactions to Contrast Media

  • E. C. Lasser
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 73)

Abstract

Toxic effects resulting from contrast medium (CM) injections can be considered in two major categories: (a) local and (b) systemic. Local toxicity results from injections of high concentrations and/or quantities of CM into a vessel supplying an organ or tissue. Ultimately, the degree of toxicity must be a function of the concentration and the application time of the injected material. Hence, such factors as organic luminal obstructions, functional obstructions, viscosity changes, and other hemodynamic alterations that prolong the application time increase the chemo toxicity of the injected CM. The precise etiology of chemotoxicity is still poorly understood, but it is thought to involve such factors as molecular interference with functional proteins such as enzymes and regulators and/or hyperosmolarity of the CM solution. Underlying the potential of CM to act as general enzyme inhibitors is their ability to bind to proteins. Such binding appears to reflect principally the degree of hydrophobicity of the CM molecules [1–5]. The correlation between the lethal doses of CM in experimental animals and the binding of CM to serum albumins and various enzymes has been established [6]. In a series of studies, all the CM investigated, if present in sufficiently high concentrations, inhibited the enzymes tested [1–3]. The concentrations and total dosages of CM used in intravascular studies are so high that it is not surprising to find downstream from an intravascular injection a concentration of CM sufficient for a 50% inhibition of a given enzyme system in vitro.

Keywords

Toxicity Albumin Benzene Corticosteroid Iodine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lang JH, Lasser EC (1971) Nonspecific inhibition of enzymes by organic contrast media. J Med Chem 14:233–236PubMedCrossRefGoogle Scholar
  2. 2.
    Lasser EC, Lang JH (1970) Physiologic significance of contrast-protein interactions. I. Study in vitro of some enzyme effects. Invest Radiol 5:514–517PubMedCrossRefGoogle Scholar
  3. 3.
    Lang JH, Lasser EC (1975) Inhibition of adenosine triphosphatase and carbonic anhy-drase by contrast media. Invest Radiol 10:314–316PubMedCrossRefGoogle Scholar
  4. 4.
    Lasser EC, Lang JH (1970) Contrast-protein interactions. The symposium on contrast media toxicity of the association of University Radiologists, Skytop, May 3–6, 1970. Invest Radiol 5:373–502PubMedCrossRefGoogle Scholar
  5. 5.
    Lasser EC, Farr RS, Fujimagari T, Tripp WM (1962) The significance of protein-binding of contrast media in roentgen diagnosis. AJR 87:338–360Google Scholar
  6. 6.
    Han SY, Sitten DM (1974) Clinical trial of bilopaque oral cholecystography. Evaluation of time of optimal and peak opacification of the gallbladder. Radiology 112:529–531PubMedGoogle Scholar
  7. 7.
    Simon AL, Shebetai R, Lang JH, Lasser EC (1972) The mechanism of production of ventricular fibrillation in coronary angiography. AJR 114:810–816Google Scholar
  8. 8.
    Golman K (1979) The blood-brain barrier: effects of nonionic contrast media with and without addition of Ca2 + and Mg2 +. Invest Radiol 14:305–308PubMedCrossRefGoogle Scholar
  9. 9.
    Ausman JI, Young R, Owens G (1964) Radio-opaque dyes and other agents in the production of endothelial damage. J Surg Res 4:349–355PubMedCrossRefGoogle Scholar
  10. 10.
    Waldron RL, Bridenbaugh RB, Dempsey EW (1974) Effect of angiographic contrast media at the cellular level in the brain: hypertonic vs. chemical action. AJR 122:469–476Google Scholar
  11. 11.
    Cogen FC, Norman ME, Dunsky E, Hirshfeld J, Zweiman B (1979) Histamine release and complement changes following injection of contrast media in humans. J Allergy Clin Immunol 64:200–303CrossRefGoogle Scholar
  12. 12.
    Ring J, Arroyave CM (1979) Alteration of human blood cells and changes in plasma mediators produced by radiographic contrast media. Z Immunitaetsforsch Immunobiol 155:200–211Google Scholar
  13. 13.
    Ansell G, Tweedie MCK, West CR, Evans P, Couch L (1980) The current status of reactions to intravenous contrast media. Material presented at international contrast material symposium, Colorado Springs, May 1979. Invest Radiol 515:32–39CrossRefGoogle Scholar
  14. 14.
    Lasser EC, Walters AJ, Lang JH (1974) An experimental basis for histamine release in contrast material reactions. Radiology 110:49PubMedGoogle Scholar
  15. 15.
    Rockoff SD, Brasch R (1971) Contrast media as histamine liberators. III. Histamine release and some associated hemodynamic effects during pulmonary angiography in the dog. Invest Radiol 6:110PubMedCrossRefGoogle Scholar
  16. 16.
    Rockoff SD, Brasch R (1972) Contrast media as histamine liberators. V. Comparison of in vitro mast cell histamine release by sodium and methylglucamine salts. Invest Radiol 7:177PubMedCrossRefGoogle Scholar
  17. 17.
    Seidel G, Groppe G, Meyer-Burgdorff HC (1974) Contrast media as histamine liberators in man. Agents Actions 4:143PubMedCrossRefGoogle Scholar
  18. 18.
    Arroyave CM, Bhat KH, Crown R (1976) Activation of the alternative pathway of the complement system by radiographic contrast media. J Immunol 117:1866PubMedGoogle Scholar
  19. 19.
    Siegle RL, Lieberman P (1976) Measurement of histamine, complement components and immune complexes during patient reactions to iodinated contrast material. Invest Radiol 11:98–101PubMedCrossRefGoogle Scholar
  20. 20.
    Ring J, Arroyave CM, Fritzler MJ, Tan EM (1978) In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol 32:105–118PubMedGoogle Scholar
  21. 21.
    Ring J, Endrich B, Intaglietta M (1978) Histamine release, complement consumption and microvascular changes after radiographic contrast media infusion in rabbits. J Lab Clin Med 92:584PubMedGoogle Scholar
  22. 22.
    Arroyave CM (1980) An in vitro assay for radiographic contrast media idiosyncrasy. Presented at international contrast material symposium, Colorado Springs, May 1979. Invest Radiol 15:21–25CrossRefGoogle Scholar
  23. 23.
    Brasch R, Caldwell JL, Fudenberg HH (1976) Antibodies to radiographic contrast agents. Induction and characterization of rabbit antibody. Invest Radiol 2:1–9CrossRefGoogle Scholar
  24. 24.
    Brasch RC, Caldwell JL (1976) The allergic theory of radiocontrast agent toxicity: demonstration of antibody activity and sera of patients suffering major radiocontrast agent reactions. Invest Radiol 2:347–356CrossRefGoogle Scholar
  25. 25.
    Brasch RC (1980) Allergic reactions to contrast media: accumulated evidence. AJR 134:797–801PubMedGoogle Scholar
  26. 26.
    Wakkers-Garritsen BG, Houwerziji J, Nater JP, Wakkers PJM (1976) IgE-mediated adverse reactivity to a radiographic contrast medium — case report. Ann Allergy 36:122–126PubMedGoogle Scholar
  27. 27.
    Lalli AF (1974) Urographic contrast media reactions and anxiety. Radiology 112:267–271PubMedGoogle Scholar
  28. 28.
    Lasser EC, Sovak M, Lang JH (1976) Development of contrast media idiosyncrasy in the dog. Radiology 119:91–95PubMedGoogle Scholar
  29. 29.
    Kolb WP, Lang JH, Lasser EC (1978) Nonimmunologic complement activation in normal human serum induced by X-ray contrast media. J Immunol 121:1232–1238PubMedGoogle Scholar
  30. 30.
    Till G, Rother U, Gemsa D (1978) Activation of complement by radiographic contrast media. Int Arch Allergy Appl Imunol 56:543–550CrossRefGoogle Scholar
  31. 31.
    Arroyave CM, Bhat K, Crown R (1976) Activation of serum complement by contrast media. J Immunol 117:866–869Google Scholar
  32. 32.
    Lang JH, Lasser EC, Kolb WP (1976) Activation of the complement system by X-ray contrast media. Invest Radiol 11:303–308PubMedCrossRefGoogle Scholar
  33. 33.
    Lasser EC, Lang JH, Sovak M, Kolb WP, Lyon SG, Hamblin AE (1977) Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactions. Radiology 125:1–9PubMedGoogle Scholar
  34. 34.
    Lasser EC, Slivka J, Lang JH, Kolb WP, Lyon SG, Hamblin AE, Nazareno G (1979) Complement and coagulation — causative considerations in contrast catastrophes. AJR 132:171–176PubMedGoogle Scholar
  35. 35.
    Lasser EC, Lang JH, Lyon SG, Hamblin AE (1979) Complement and contrast material reactors. J Allergy Clin Immunol 64:102–112CrossRefGoogle Scholar
  36. 36.
    Lasser EC, Lang JH, Lyon SG, Hamblin AE (1980) Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material: some considerations of pathogenesis. Presented at international contrast material symposium, Colorado Springs, May 1979. Invest Radiol 15:6–12CrossRefGoogle Scholar
  37. 37.
    Zeman RK (1977) Disseminated intravascular coagulation following intravenous pyelography. (letter) Invest Radiol 12:203–204PubMedCrossRefGoogle Scholar
  38. 38.
    Wieners H (1977) Klinisch-immunologische Probleme bei der Kontrastmittelanwendung bei Gammapathien und Erkrankungen des rheumatischen Formenkreises. Symposium on adverse reactions to contrast media, Schering, Berlin, pp 67–69Google Scholar
  39. 39.
    Lasser EC, Lang JH, Lyon SG, Hamblin AE, Howard MM (1981) Glucocorticoid-induced elevations of CI-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits. Invest Radiol 16:20–23PubMedCrossRefGoogle Scholar
  40. 40.
    Osterud B (1979) The role of endothelial cells and subendothelial components in the initiation of blood coagulation. Haemostasis 8:324–331PubMedGoogle Scholar
  41. 41.
    Lasser EC, Lang JH, Lyon SG, Hamblin AE, Howard MM (1981) Prekallikrein-kallikrein conversion: conversion rates as a predictor for contrast catastrophes. Radiology 140:11–15PubMedGoogle Scholar
  42. 42.
    Yocum NW, Heller AM, Abels RI (1978) Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media-sensitive patients. J Allergy Clin Immunol 62:309–313PubMedCrossRefGoogle Scholar
  43. 43.
    Shehadi WN (1975) Adverse reactions to intravascularly administered contrast media: a comprehensive study based on a prospective study. AJR 124:145–152Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • E. C. Lasser

There are no affiliations available

Personalised recommendations